BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20861311)

  • 1. Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1.
    Lin S; Gordon K; Kaplan N; Getsios S
    Mol Biol Cell; 2010 Nov; 21(22):3902-14. PubMed ID: 20861311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA2 Transmembrane Domain Is Uniquely Required for Keratinocyte Migration by Regulating Ephrin-A1 Levels.
    Ventrella R; Kaplan N; Hoover P; Perez White BE; Lavker RM; Getsios S
    J Invest Dermatol; 2018 Oct; 138(10):2133-2143. PubMed ID: 29705292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis.
    Gordon K; Kochkodan JJ; Blatt H; Lin SY; Kaplan N; Johnston A; Swindell WR; Hoover P; Schlosser BJ; Elder JT; Gudjonsson JE; Getsios S
    J Invest Dermatol; 2013 Mar; 133(3):712-722. PubMed ID: 23190894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N; Mohammed KA; Lai Y; Antony VB
    Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
    Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
    BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
    Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
    Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
    J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines.
    Minami M; Koyama T; Wakayama Y; Fukuhara S; Mochizuki N
    Mol Biol Cell; 2011 Sep; 22(18):3508-19. PubMed ID: 21795402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB; Stockhausen MT; Poulsen HS
    Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
    Cuyàs E; Queralt B; Martin-Castillo B; Bosch-Barrera J; Menendez JA
    Oncol Rep; 2017 Jul; 38(1):263-270. PubMed ID: 28560458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
    Xu Q; Lin WC; Petit RS; Groves JT
    Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.
    Saeki N; Nishino S; Shimizu T; Ogawa K
    Cell Adh Migr; 2015; 9(6):469-82. PubMed ID: 26565750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis.
    Getsios S; Simpson CL; Kojima S; Harmon R; Sheu LJ; Dusek RL; Cornwell M; Green KJ
    J Cell Biol; 2009 Jun; 185(7):1243-58. PubMed ID: 19546243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling.
    Kaplan N; Ventrella R; Peng H; Pal-Ghosh S; Arvanitis C; Rappoport JZ; Mitchell BJ; Stepp MA; Lavker RM; Getsios S
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):393-406. PubMed ID: 29351356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
    Pratt RL; Kinch MS
    Oncogene; 2002 Oct; 21(50):7690-9. PubMed ID: 12400011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
    Yang XY; Zhu WJ; Jiang H
    Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
    Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin A1 promotes proliferation of bovine endometrial cells with abundant expression of proliferating cell nuclear antigen and cyclin D1 changing the cell population at each stage of the cell cycle.
    Lim W; Bae H; Bazer FW; Song G
    J Cell Physiol; 2019 Apr; 234(4):4864-4873. PubMed ID: 30238980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.
    Konda N; Saeki N; Nishino S; Ogawa K
    Histochem Cell Biol; 2017 Mar; 147(3):317-339. PubMed ID: 27665280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.